FundLens
33
Pharma & HealthcareAvoid

Tata India Pharma & Healthcare

Tata · Direct–Growth · rank #16 / 18 Smart Score ke hisaab se

Data updated

Tata India Pharma & Healthcare ka score 33/100 hai — 18 mein #16 Pharma & Healthcare fund (Avoid). Mazbooti: expense ratio (category mein 75th percentile). Kamzori: 3 saal ka return (category mein 23th percentile).

Trailing returns

index ke muqable: Nifty 500 (index-fund proxy)
1 saal
10.1%
+7.4% index ke muqable
3 saal
20.7%
+9.3% index ke muqable
5 saal
14.6%
+4.3% index ke muqable
Launch se
13.7%

Saal-dar-saal performance

aakhri entry = is saal ab tak
2021
20.9%
2022
-6.6%
2023
38.6%
2024
42.5%
2025
-3.5%
2026
11.7%

Risk metrics

Sharpe ratio
0.93
↑ jitna zyada, utna accha
Sortino ratio
1.53
↑ jitna zyada, utna accha
Std deviation
16.41
↓ jitna kam, utna accha
Alpha
-0.02
↑ jitna zyada, utna accha
Beta
0.98
≈1 yaani market ke saath

Isi category ke aur funds

Research aur education ke liye — investment advice nahi.